The leading cause of irreversible blindness is glaucoma, a disease normally characterized
by the development of ocular hypertension and consequent damage to the optic nerve at its …

Objective To provide the results of the Early Manifest Glaucoma Trial, which compared the
effect of immediately lowering the intraocular pressure (IOP), vs no treatment or later …

Background Primary open-angle glaucoma (POAG) is one of the leading causes of
blindness in the United States and worldwide. Three to 6 million people in the United States …

methods. Experimental glaucoma was induced unilaterally in 174 Wistar rats, using a diode
laser with wavelength of 532 nm aimed at the trabecular meshwork and episcleral veins …

PURPOSE: To explore recent studies and clinical experience involving the importance of 24-
hour control of intraocular pressure (IOP) in patients with glaucoma. METHODS: Roundtable …

Objective To compare bimatoprost with timolol maleate in patients with glaucoma or ocular
hypertension. Methods In 2 identical, multicenter, randomized, double-masked, 1-year …

PURPOSE: To compare patients becoming legally blind from glaucoma with those who did
not go blind. DESIGN: Retrospective, cohort, and case-control study. METHODS: A …

purpose. To report the prevalence of blindness and visual impairment and the contribution of
uncorrected refractive error to visual loss, in a population-based sample of Mexican …

BACKGROUND: Many ophthalmologists instruct patients with glaucoma to avoid coffee,
although data supporting this practice are insufficient. OBJECTIVE: To estimate the effect of …

Purpose. To evaluate the intraocular pressure (IOP)-reducing effect of the fixed combination
of 0.005% latanoprost and 0.5% timolol compared with the individual monotherapies …